Profil Penderita Covid-19 dengan Komorbid Penyakit Jantung Koroner di Rumah Sakit Umum Haji Surabaya
DOI:
https://doi.org/10.30649/htmj.v19i2.157Kata Kunci:
COVID-19, komorbid, penyakit jantung koroner, profilAbstrak
Latar belakang : COVID-19 adalah penyakit yang disebabkan jenis baru virus corona yang masih memiliki hubungan dengan famili virus SARS. Kasus COVID-19 pertama kali muncul di Wuhan dan menyebar melalui transmisi kontak individu terkontaminasi, kontaminasi droplet, fomites. COVID-19 muncul di Indonesia tahun 2020. Faktor resiko paparan COVID-19 yaitu penyakit komorbid seperti penyakit jantung. Penyakit jantung koroner adalah inflamasi kronis dengan karakteristik penyempitan arteri koroner. Komorbid PJK memperburuk klinis pasien COVID-19.
Metode : Penelitian ini deskriptif dengan metode kuantitatif menggunakan data sekunder. Populasi penelitian adalah rekam medis pasien COVID-19 dengan riwayat komorbid penyakit jantung koroner di poli jantung Rumah Sakit Umum Haji Surabaya pada periode 1 Juni 2020 hingga 31 Agustus 2021. Teknik pengambilan sampel adalah total sampling, semua populasi dipilih apabila memenuhi kriteria penelitian hingga kurun waktu tertentu. Variabel yang diteliti yaitu usia, jenis kelamin, tekanan darah, suhu tubuh, IMT, hemoglobin, sel darah merah, sel darah putih, platelet, hematokrit, PPT, aPTT, d-Dimer, elektrokardiogram. Data yang diperoleh dianalisa dalam secara deskriptif dan disajikan dalam tabel.
Hasil : Penelitian ini menunjukkan profil penderita COVID-19 dengan komorbid penyakit jantung koroner di Rumah Sakit Umum Haji Surabaya paling sering pada rentang usia 56 – 65 tahun, sering pada pria, dengan tanda – tanda vital normal. IMT berdampak pada kerentanan seseorang terhadap paparan dan faktor resiko COVID-19 serta penyakit jantung koroner, terutama individu obesitas. CBC menunjukkan nilai rata – rata normal dan pemeriksaan PPT, APTT mayoritas normal. Abnormalitas status d-dimer pasien meningkat, mengindikasi peningkatan koagulasi pada darah, serta abnormalitas pada interpretasi EKG (elektrokardiogram) mengindikasi ketidaknormalan kerja jantung.
Referensi
Cassar, A. et al. (2009) ‘Chronic coronary artery disease: Diagnosis and management’, Mayo Clinic Proceedings, 84(12), pp. 1130–1146. doi: 10.4065/mcp.2009.0391.
Chowdhury, S. D. and Oommen, A. M. (2020) ‘Epidemiology of COVID-19’, pp. 3–7.
Clerkin, K. J. et al. (2020) ‘COVID-19 and Cardiovascular Disease’, Circulation, 2019, pp. 1648–1655. doi: 10.1161/CIRCULATIONAHA.120.046941.
Coronavirus disease (COVID-19) (no date). Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19#:~:text=symptoms (Accessed: 1 August 2021).
Ghani, L., Susilawati, M. D. and Novriani, H. (2016) ‘Faktor Risiko Dominan Penyakit Jantung Koroner di Indonesia’, Buletin Penelitian Kesehatan, 44(3), pp. 153–164. doi: 10.22435/bpk.v44i3.5436.153-164.
Guan, W. J. et al. (2020) ‘Cardiovascular comorbidity and its impact on patients with COVID-19’, European Respiratory Journal, 55(6). doi: 10.1183/13993003.01227-2020.
Huang, C. et al. (2020) ‘Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China’, The Lancet, 395(10223), pp. 497–506. doi: 10.1016/S0140-6736(20)30183-5.
Huang, G., Kovalic, A. J. and Graber, C. J. (2020) ‘Prognostic value of leukocytosis and lymphopenia for coronavirus disease severity’, Emerging Infectious Diseases, 26(8), pp. 1839–1841. doi: 10.3201/eid2608.201160.
Indonesia: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data (no date). Available at: https://covid19.who.int/region/searo/country/id (Accessed: 1 August 2021).
Kementerian Kesehatan Republik Indonesia (no date). Available at: https://www.kemkes.go.id/index.php?txtKeyword=status+gizi&act=search-by-map&pgnumber=0&charindex=&strucid=1280&fullcontent=1&C-ALL=1 (Accessed: 27 September 2021).
Liang, C. et al. (2021) ‘Coronary heart disease and COVID-19 : A meta-analysis’, 156, pp. 547–554.
Libby, P. and Theroux, P. (2005) ‘Pathophysiology of coronary artery disease’, Circulation, 111(25), pp. 3481–3488. doi: 10.1161/CIRCULATIONAHA.105.537878.
Liu, K. et al. (2020) ‘Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients’, Journal of Infection, 80(6), pp. e14–e18. doi: 10.1016/j.jinf.2020.03.005.
Lowe, G. D. O. (2005) ‘Fibrin D-Dimer and Cardiovascular Risk’.
Parasher, A. (2021) ‘COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment’, Postgraduate Medical Journal, 97(1147), pp. 312–320. doi: 10.1136/postgradmedj-2020-138577.
Pooling, T. H. E. (1978) ‘RELATIONSHIP OF BLOOD PRESSURE , SERUM CHOLESTEROL , SMOKING HABIT , RELATIVE WEIGHT AND ECG ABNORMALITIES TO INCIDENCE OF MAJOR CORONARY EVENTS : FINAL REPORT OF THE POOLING PROJECT’, 31, pp. 201–306.
Pourbagheri-sigaroodi, A. et al. (2020) ‘Clinica Chimica Acta Laboratory fi ndings in COVID-19 diagnosis and prognosis’, 510(August), pp. 475–482.
Unicef, WHO and IFRC (2020) ‘Key Messages and Actions for Prevention and Control in Schools’, Key Messages and Actions for COVID-19 Prevention and Control in Schools, (March), p. 13. Available at: https://www.who.int/docs/default-source/coronaviruse/key-messages-and-actions-for-covid-19-prevention-and-control-in-schools-march-2020.pdf?sfvrsn=baf81d52_4#:~:text=COVID-19 is a,2019-nCoV.’.
Yustinawati, R. and Achadi, A. (2020) ‘RISK FACTORS FOR MORTALITY IN PATIENTS WITH COVID-19 : A SYSTEMATIC REVIEW The 7th International Conference on Public Health Solo , Indonesia , November 18-19 , 2020 | 1 The 7th International Conference on Public Health Solo , Indonesia , November 18-19 ’, pp. 1–11.
Zhang, S. fen et al. (2018) ‘Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou’, PLoS ONE, 13(1), pp. 1–20. doi: 10.1371/journal.pone.0191789.
